MSTZ and AFSC Experience Significant ETF Withdrawals
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 17 2025
0mins
Source: NASDAQ.COM
ETF Outflow Details: The Abrdn Focused US Small Cap Active ETF experienced the largest outflow, losing 450,000 units, which is a 36.3% decline in outstanding units compared to the previous week.
Market Performance of Components: In morning trading, Ligand Pharmaceuticals saw a slight increase of about 0.6%, while American Healthcare Reit rose by approximately 1%.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy AHR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on AHR
Wall Street analysts forecast AHR stock price to rise
12 Analyst Rating
11 Buy
1 Hold
0 Sell
Strong Buy
Current: 53.650
Low
47.00
Averages
55.25
High
60.00
Current: 53.650
Low
47.00
Averages
55.25
High
60.00
About AHR
American Healthcare REIT, Inc. is a self-managed real estate investment trust that acquires, owns and operates a diversified portfolio of clinical healthcare real estate properties, focusing primarily on senior housing, skilled nursing facilities (SNFs), outpatient medical (OM), buildings and other healthcare-related facilities. It owns and operates its integrated senior health campuses (ISHC) and senior housing operating properties (SHOP). Its segments include ISHC, OM, SHOP and triple-net leased properties. ISHC segment provides a range of independent living, assisted living, memory care, skilled nursing services and certain ancillary businesses. OM segment includes buildings that are leased to multiple tenants under separate leases. SHOP segment includes senior housing, which offers assisted living care, independent living, memory care or skilled nursing services. Its triple-net leased properties segment includes senior housing, skilled nursing facilities and hospital investments.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Citi Upgrades American Healthcare REIT to Buy, Downgrades Sabra Health Care
- Rating Changes: Citi upgraded American Healthcare REIT (AHR) from Neutral to Buy while downgrading Sabra Health Care (SBRA) from Buy to Neutral, as analyst Seth Bergey views AHR's relative underperformance as an attractive entry point for investors.
- Market Reaction: In Tuesday's premarket trading, SBRA's stock fell by 2.2%, while AHR remained unchanged, indicating a divergent market response to the rating changes and reflecting increased investor confidence in AHR.
- Operational Model Comparison: Bergey noted that while SBRA's platform benefits from experienced management and strong operator relationships, it offers less operational upside compared to AHR's vertically integrated model, suggesting greater growth potential for AHR in the future.
- Investment Advantages: Citi's preference for AHR is driven by its widening relative investment spread advantage as its senior housing operating portfolio acquisition yields compress, with a prefunded acquisition pipeline expected to support upward earnings revisions and an owned operating platform (Trilogy) capable of driving sustained internal growth.
See More
Major Rating Changes on Wall Street
- IBM Upgrade: JPMorgan upgraded IBM from Neutral to Overweight, citing a deeper analysis of its software business that suggests significant performance acceleration in 2H'26, thereby enhancing market confidence in the company's growth trajectory.
- Qiagen Upgrade: Morgan Stanley upgraded Qiagen from Equal Weight to Overweight, noting that AI-driven growth improvements and the clearing of competitive risks are expected to positively impact the life sciences sector.
- Smurfit Westrock Initiation: Deutsche Bank initiated coverage of Smurfit Westrock with a Buy rating and a $57 price target, emphasizing its high-margin operations and strong market position as catalysts for value creation in the packaging industry.
- Target Upgrade: Wolfe upgraded Target from Peer Perform to Outperform, stating that now is the optimal time to buy, as the company is poised for significant improvements driven by store resets and a new leadership team shaking up the status quo.
See More
American Healthcare REIT Declares Quarterly Dividend
- Quarterly Dividend Announcement: American Healthcare REIT (AHR) has declared a quarterly dividend of $0.25 per share, consistent with previous distributions, indicating the company's stable cash flow and shareholder return strategy.
- Yield Information: The forward yield of this dividend stands at 2.15%, reflecting the company's attractiveness in the current market environment, which may draw more investor attention to its stock.
- Shareholder Record Date: The dividend will be payable on July 17, with a record date of June 30 and an ex-dividend date also on June 30, ensuring shareholders receive their dividends in a timely manner.
- Market Attractiveness Analysis: AHR is listed among the least attractively valued mid-cap stocks in the U.S., indicating market caution regarding its future growth potential, which could influence investor decisions.
See More
U.S. Jobs Data Triggers Market Volatility
- Jobs Data Impact: The unexpected addition of 172,000 jobs in May 2026 raised concerns among investors about the Federal Reserve maintaining high interest rates, leading to a sharp market retreat that highlights the tension between economic resilience and high-rate anxiety.
- Geopolitical Tensions Escalate: Renewed missile exchanges between Iran and Israel threaten the stability of the April ceasefire, adding to market uncertainty, particularly regarding maritime security in the critical Strait of Hormuz.
- Low-Leverage Stock Recommendations: In light of high volatility, investors are advised to consider low-leverage companies such as HF Sinclair, Siemens Energy, American Healthcare REIT, Par Pacific, and Green Dot to navigate interest rate fluctuations and geopolitical risks effectively.
- Financial Leverage Risk Analysis: Investors should monitor the debt-to-equity ratios of companies, as lower ratios typically indicate better solvency; selecting low-leverage firms can help ensure steady returns during economic downturns.
See More
Valuation Grades of U.S. Mid-Cap REITs Highlight Market Leaders
- Valuation Overview: Seeking Alpha's valuation grades reveal that U.S. mid-cap REITs, with market capitalizations between $2B and $10B, exhibit several companies with high valuation levels, indicating a lack of attractiveness compared to sector peers.
- Least Attractive Stocks: Companies such as American Healthcare REIT (AHR), Curbline Properties (CURB), Janus Living (JAN), and Terreno Realty (TRNO) received an F rating, suggesting extremely low investment appeal in the current market, which may hinder their future financing capabilities.
- Mid-Cap REIT Performance: First Industrial Realty Trust (FR), Fermi Inc. (FRMI), Vornado Realty Trust (VNO), Acadia Realty Trust (AKR), and InvenTrust Properties (IVT) all received a D rating, indicating insufficient competitiveness in the market and potential increased market pressure.
- Future Outlook: While Macerich has set a 2028 FFO target of $1.80 to $2.00 per share, overall market confidence in mid-cap REITs is suppressed, particularly in the current economic environment, prompting investors to carefully assess these companies' long-term potential.
See More
American Healthcare REIT Prices Public Offering of 14 Million Shares
- Offering Size: American Healthcare REIT announced a public offering of 14 million shares of common stock, expected to generate approximately $705.6 million in gross proceeds, with a closing date set for May 22, 2026, indicating the company's proactive approach to capital markets.
- Underwriter Role: BofA Securities acts as the underwriter for the offering and has been granted a 30-day option to purchase an additional 2.1 million shares, which could further enhance the company's capital structure and liquidity if exercised.
- Forward Sale Agreement: The company entered into a forward sale agreement with BofA Securities, expecting to settle within 24 months, and if the underwriter's option is fully exercised, the total shares could increase to 16.1 million, thereby boosting the company's financing capabilities in the market.
- Planned Use of Proceeds: The company intends to contribute the net proceeds from the forward sale agreement to its operating partnership, highlighting its focus on future investment opportunities and aiming to enhance overall business growth potential.
See More
Citi Upgrades American Healthcare REIT to Buy, Downgrades Sabra Health Care
- Rating Changes: Citi upgraded American Healthcare REIT (AHR) from Neutral to Buy while downgrading Sabra Health Care (SBRA) from Buy to Neutral, as analyst Seth Bergey views AHR's relative underperformance as an attractive entry point for investors.
- Market Reaction: In Tuesday's premarket trading, SBRA's stock fell by 2.2%, while AHR remained unchanged, indicating a divergent market response to the rating changes and reflecting increased investor confidence in AHR.
- Operational Model Comparison: Bergey noted that while SBRA's platform benefits from experienced management and strong operator relationships, it offers less operational upside compared to AHR's vertically integrated model, suggesting greater growth potential for AHR in the future.
- Investment Advantages: Citi's preference for AHR is driven by its widening relative investment spread advantage as its senior housing operating portfolio acquisition yields compress, with a prefunded acquisition pipeline expected to support upward earnings revisions and an owned operating platform (Trilogy) capable of driving sustained internal growth.
See More
Major Rating Changes on Wall Street
- IBM Upgrade: JPMorgan upgraded IBM from Neutral to Overweight, citing a deeper analysis of its software business that suggests significant performance acceleration in 2H'26, thereby enhancing market confidence in the company's growth trajectory.
- Qiagen Upgrade: Morgan Stanley upgraded Qiagen from Equal Weight to Overweight, noting that AI-driven growth improvements and the clearing of competitive risks are expected to positively impact the life sciences sector.
- Smurfit Westrock Initiation: Deutsche Bank initiated coverage of Smurfit Westrock with a Buy rating and a $57 price target, emphasizing its high-margin operations and strong market position as catalysts for value creation in the packaging industry.
- Target Upgrade: Wolfe upgraded Target from Peer Perform to Outperform, stating that now is the optimal time to buy, as the company is poised for significant improvements driven by store resets and a new leadership team shaking up the status quo.
See More
American Healthcare REIT Declares Quarterly Dividend
- Quarterly Dividend Announcement: American Healthcare REIT (AHR) has declared a quarterly dividend of $0.25 per share, consistent with previous distributions, indicating the company's stable cash flow and shareholder return strategy.
- Yield Information: The forward yield of this dividend stands at 2.15%, reflecting the company's attractiveness in the current market environment, which may draw more investor attention to its stock.
- Shareholder Record Date: The dividend will be payable on July 17, with a record date of June 30 and an ex-dividend date also on June 30, ensuring shareholders receive their dividends in a timely manner.
- Market Attractiveness Analysis: AHR is listed among the least attractively valued mid-cap stocks in the U.S., indicating market caution regarding its future growth potential, which could influence investor decisions.
See More
U.S. Jobs Data Triggers Market Volatility
- Jobs Data Impact: The unexpected addition of 172,000 jobs in May 2026 raised concerns among investors about the Federal Reserve maintaining high interest rates, leading to a sharp market retreat that highlights the tension between economic resilience and high-rate anxiety.
- Geopolitical Tensions Escalate: Renewed missile exchanges between Iran and Israel threaten the stability of the April ceasefire, adding to market uncertainty, particularly regarding maritime security in the critical Strait of Hormuz.
- Low-Leverage Stock Recommendations: In light of high volatility, investors are advised to consider low-leverage companies such as HF Sinclair, Siemens Energy, American Healthcare REIT, Par Pacific, and Green Dot to navigate interest rate fluctuations and geopolitical risks effectively.
- Financial Leverage Risk Analysis: Investors should monitor the debt-to-equity ratios of companies, as lower ratios typically indicate better solvency; selecting low-leverage firms can help ensure steady returns during economic downturns.
See More
Valuation Grades of U.S. Mid-Cap REITs Highlight Market Leaders
- Valuation Overview: Seeking Alpha's valuation grades reveal that U.S. mid-cap REITs, with market capitalizations between $2B and $10B, exhibit several companies with high valuation levels, indicating a lack of attractiveness compared to sector peers.
- Least Attractive Stocks: Companies such as American Healthcare REIT (AHR), Curbline Properties (CURB), Janus Living (JAN), and Terreno Realty (TRNO) received an F rating, suggesting extremely low investment appeal in the current market, which may hinder their future financing capabilities.
- Mid-Cap REIT Performance: First Industrial Realty Trust (FR), Fermi Inc. (FRMI), Vornado Realty Trust (VNO), Acadia Realty Trust (AKR), and InvenTrust Properties (IVT) all received a D rating, indicating insufficient competitiveness in the market and potential increased market pressure.
- Future Outlook: While Macerich has set a 2028 FFO target of $1.80 to $2.00 per share, overall market confidence in mid-cap REITs is suppressed, particularly in the current economic environment, prompting investors to carefully assess these companies' long-term potential.
See More
American Healthcare REIT Prices Public Offering of 14 Million Shares
- Offering Size: American Healthcare REIT announced a public offering of 14 million shares of common stock, expected to generate approximately $705.6 million in gross proceeds, with a closing date set for May 22, 2026, indicating the company's proactive approach to capital markets.
- Underwriter Role: BofA Securities acts as the underwriter for the offering and has been granted a 30-day option to purchase an additional 2.1 million shares, which could further enhance the company's capital structure and liquidity if exercised.
- Forward Sale Agreement: The company entered into a forward sale agreement with BofA Securities, expecting to settle within 24 months, and if the underwriter's option is fully exercised, the total shares could increase to 16.1 million, thereby boosting the company's financing capabilities in the market.
- Planned Use of Proceeds: The company intends to contribute the net proceeds from the forward sale agreement to its operating partnership, highlighting its focus on future investment opportunities and aiming to enhance overall business growth potential.
See More
